IGF-I sensitivity in Silver-Russell syndrome with IGF2/H19 hypomethylation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Growth Hormone & IGF Research

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ghir.2014.06.005PMID 25066218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IGF2/H19 hypomethylation is tissue, cell, and CpG site dependent and not correlated with body asymmetry in adolescents with Silver-Russell syndrome

  2012cited by this paper
• Post-receptor IGF1 insensitivity restricted to the MAPK pathway in a Silver-Russell syndrome patient with hypomethylation at the imprinting control region on chromosome 11.

  2012cited by this paper
• Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation.

  2010cited by this paper
• Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci.

  2009cited by this paper
• Akt phosphorylation in lymphocytes provides an index of in vitro insulin-like growth factor I sensitivity associated with growth hormone-induced growth.

  2008cited by this paper
• Epigenetic mutations of the imprinted IGF2-H19 domain in Silver–Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes

  2008cited by this paper
• The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration.

  2008cited by this paper
• IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus.

  2006cited by this paper
• Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome

  2005influential reference
• Screening for Insulin-like Growth Factor-I Receptor Mutations in Patients with Silver-Russell Syndrome

  2002cited by this paper
• The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.

  1999cited by this paper
• The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation*

  1999cited by this paper
• Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 Pathway*

  1998cited by this paper
• Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology.

  1998cited by this paper
• Maternal uniparental disomy 7 in Silver-Russell syndrome.

  1997cited by this paper
• Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development.

  1997influential reference
• Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation.

  1995cited by this paper
• 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators

  1991cited by this paper
• [Growth hormone and insulin-like growth factor].

  1990cited by this paper
• Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

  1989cited by this paper
• A Methodology for Evaluating Size at Birth

  1985cited by this paper
• A syndrome of intra-uterine dwarfism recognizable at birth with cranio-facial dysostosis, disproportionately short arms, and other anomalies (5 examples).

  1954cited by this paper
• Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotropins.

  1953cited by this paper

• Overexpression of Igf2-derived Mir483 inhibits Igf1 expression and leads to developmental growth restriction and metabolic dysfunction in mice

  2024cites this paper
• IGF1 Haploinsufficiency: Phenotype and Response to Growth Hormone Treatment in 9 Patients

  2024cites this paper
• Novel Insights Into the Genetic Causes of Short Stature in Children

  2022cites this paper
• The imprinted Mir483 is a growth suppressor and metabolic regulator functioning through IGF1

  2022cites this paper
• Clinical and Molecular Heterogeneity of Silver Russell Syndrome and Therapeutic Challenges: A Systematic Review.

  2022cites this paper
• The Emerging Role of Glucose Metabolism in Cartilage Development

  2019cites this paper
• Sleep disordered breathing in Silver-Russell syndrome patients: a new outcome.

  2019cites this paper
• Systemic signalling and local effectors in developmental stability, body symmetry, and size

  2018cites this paper
• Short stature in genetic syndromes: Selected issues.

  2018cites this paper
• Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

  2018cites this paper
• Retard de croissance staturo-pondéral révélant un syndrome de Silver Russell associé à une composante inédite

  2017cites this paper
• Short children born small for gestational age outcomes in the era of growth hormone therapy.

  2017cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Novel genetic causes of short stature.

  2016cites this paper
• New clinical and molecular insights into Silver–Russell syndrome

  2016cites this paper